Les villes allemandes de Berlin et Munich ont suspendu mardi les vaccinations avec le vaccin AstraZeneca pour les moins de 60 ans, alors que de nouveaux rapports font état de caillots sanguins parmi les personnes qui en ont reçu. </p><div> <p>«Nous arrêtons provisoirement les vaccinations avec AstraZeneca pour les moins de 60 ans», a déclaré le ministre de la Santé de Berlin, Dilek Kalayci, citant «de nouvelles données sur les effets secondaires».
She said it was a “precautionary measure” pending an official recommendation from federal health officials.
The southern city of Munich announced its own suspension shortly thereafter and reports suggest the Brandenburg region followed suit.
Germany’s regional and federal health ministers will meet shortly on Tuesday evening, and the vaccines committee is expected to make a new recommendation soon.
“We don’t have serious cases of side effects in Berlin,” Kalayci said, adding that “everyone who has ever had a first injection of AstraZeneca has very good protection”.
The German Medicines Regulatory Institute Paul Ehrlich (PEI) reported 31 cases of blood clots in people who received AstraZeneca, Spiegel magazine reported on Tuesday.
Almost all of the cases are believed to be in younger and middle-aged women, prompting several German hospitals to suspend use of the vaccine for women under 55 this week.
A clinic in North Rhine-Westphalia, Germany’s most populous state, said it was halting AstraZeneca shots to investigate two reported cases of thrombosis, while Charité Hospital in Berlin extended its suspension every under 60 years after Kalayci’s announcement.
On Monday, Canada also recommended ending the use of the jab for people under 55 “pending further analysis”.
The AstraZeneca vaccine has been on a rollercoaster ride, with Britain developing it strongly supporting its use, South Africa categorically rejecting it, and more than a dozen EU countries suspending the shootings in mid-March before most deployments restarted, but with an age patchwork. restrictions.
France has limited its use to those over 55, while Spain to those under 65.
Germany’s vaccination campaign has been slow, with official figures showing that around 11 percent of the population have received a first dose so far.